SCHEMBL6594792

SCHEMBL6594792

C1#Cc2ccccc2C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29283240 0.80 MAOA (0.35) —
SCHEMBL20477699 0.76 TSHR (0.42) —
SCHEMBL31251596 0.74 TSHR (0.43) —
SCHEMBL2144679 0.74 — —
SCHEMBL9630603 0.74 — —
SCHEMBL327799 0.74 TSHR (0.43) —
SCHEMBL20477815 0.74 TSHR (0.38) —
SCHEMBL4121654 0.72 — —
SCHEMBL1098772 0.69 TSHR (0.50) —
Fluoride SCHEMBL31607698 0.67 TSHR (0.48) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3303328-B1 AMINOESTER DERIVATIVES CHIESI FARM SPA (IT) 2019-03-20 — — EP claimed
EP-3152201-B1 AMINOESTER DERIVATIVES CHIESI FARM SPA (IT) 2018-08-29 — — EP claimed
EP-1036062-B1 HYDROXAMIC ACID DERIVATIVES AS MATRIX METALLOPROTEASE (MMP) INHIBITORS PFIZER LTD (GB) 2004-01-02 — — EP claimed
EP-0099057-B1 N-ACYL DERIVATIVES OF PEPTIDES, THEIR MANUFACTURE AND USE IN COMBATING DISEASES AND MEANS THEREFOR BASF Aktiengesellschaft (DE) 1987-10-14 — — EP claimed
US-20160067361-A1 ORGAN PROTECTION IN PSMA-TARGETED RADIONUCLIDE THERAPY OF PROSTATE CANCER MOLECULAR INSIGHT PHARMACEUTICALS, INC. (US) 2016-03-10 — — US disclosed
Send feedback